Showing results (131-140 of 419) with videos related to

Sort By:
Pageof 42
Transplantation|February 12, 2021
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch TestsMohamed M NasrAllah, Mahmoud Elalfy, Mervat El Ansary, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2010
Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failureBenjamin Deroure, Nassim Kamar, Helene Depreneuf, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 24, 2007
Pegylation of IFN-alpha and antiviral activityAnne Boulestin, Nassim Kamar, Karine Sandres-Sauné, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 19, 2009
Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazardsLionel Rostaing, Olivier Cointault, Pierre Marquet, et al.
Frontiers in Immunology|April 18, 2022
Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm StudyThomas Jouve, Johan Noble, Hamza Naciri-Bennani, et al.
Transplantation|August 16, 2019
The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-censored Graft SurvivalThomas Jouve, Xavier Fonrose, Johan Noble, et al.
Transplantation|December 16, 2004
Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipientsMarc Mouzin, Jean-Marc Bachaud, Nassim Kamar, et al.
Emerging Infectious Diseases|January 1, 2009
Hepatitis E virus genotype 3 diversity, FranceFlorence Legrand-Abravanel, Jean-Michel Mansuy, Martine Dubois, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2016
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized TrialLionel Rostaing, Suphamai Bunnapradist, Josep M Grinyó, et al.
Journal of Clinical Apheresis|December 22, 2020
Treatment of refractory myasthenia gravis by double-filtration plasmapheresis and rituximab: A case series of nine patients and literature reviewHamza N Bennani, Emmeline Lagrange, Johan Noble, et al.
Pageof 42